• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Laboratory testing suggests human lung tissue unimpacted by blu vapor

Bioengineer by Bioengineer
June 11, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Credit: Imperial Brands Science

A new study by Imperial Brands, owners of leading vape brand blu, contributes to the increasing evidence base substantiating vaping’s harm reduction potential compared to smoking.

The research, presented at the 58th annual meeting of the Society of Toxicology earlier this year, compared the in-vitro toxicological responses of a 3D model of human lung tissue to myblu vapour and cigarette* smoke across a range of biological endpoints.

Cells were repeatedly exposed to either 30, 60 or 90 puffs of vapour, smoke and air over 4 weeks, and the results were conclusive. While myblu vapour delivered significantly more nicotine compared to the cigarette smoke, it did not trigger any significant toxicological responses under test conditions.

Arguably the most striking observation involved the cilia on the surface of the cells- mobile, hair-like structures that line the airways and lungs, helping keep them clear of mucus and dirt. After 4 weeks of repeated exposure to undiluted myblu vapour, there was no recorded decrease in either the number of cilia, or the number of ciliated cells. In fact, tissue integrity was indistinguishable from air control. The observations were in marked contrast to cigarette smoke’s negative impact on lung cells, even when diluted at 1:17 ratio.

Dr Roman Wieczorek, Group Biological & Toxicological Laboratory Manager at Imperial Brands Science and study author, commented: “Utilising state-of-the-art in-vitro methodologies based on TT21C principles, we continue to investigate the mechanistic effects of our Next-Generation Product (NPG) portfolio to substantiate its harm reduction potential”.

“Our ethical assays use cells derived from humans. This negates the need to test on animals, while targeting multiple endpoints of direct relevance to adult smokers.”

Dr Grant O’Connell, Head of Scientific Affairs at Imperial Brands, added: “Our process of scientific substantiation focuses on all aspects of population level harm reduction, allowing us to develop robust scientific evidence packages that demonstrate the risk-reduced potential of our NGPs.

“Unfortunately, media headlines based on misleading science containing non-realistic human exposures and extrapolated results continue to prove confusing and unhelpful at best and disastrous to the global public health agenda at worst.

“Imperial Brands and blu urge public health bodies, regulators and journalists across the world to cut through the misleading, agenda-driven murk and help us in our mission to deliver something better for the world’s smokers.”

###

* Kentucky Reference Cigarette (3R4F)

Media Contact
Rob Taylor
rob.taylor@uk.imptob.com

Original Source

http://www.imperialbrandsscience.com/content/dam/imperial-brands/sciences/Library/Publications_archive/NGPs/2019/SOT%202019-P337__E-cigarettes%20induce%20..._R.Wieczorek.pdf

Tags: AddictionAnimal Research/RightsBiochemistryMedicine/HealthPublic HealthSmoking/TobaccoToxicology
Share12Tweet8Share2ShareShareShare2

Related Posts

Subjective Cognitive Decline Prediction Models Face High Bias Risk and Limited Validation

Subjective Cognitive Decline Prediction Models Face High Bias Risk and Limited Validation

November 17, 2026
Realist Review Identifies Key Strategies for Remote Health Workforce Retention

Realist Review Identifies Key Strategies for Remote Health Workforce Retention

November 17, 2026

Combined Frailty and Metabolic Index Barely Improves Cardiometabolic Multimorbidity Risk Prediction

November 17, 2026

Italian Multi-Centre Survey Highlights Gaps and Projections in Adult Metabolic Care

November 17, 2026
Please login to join discussion

POPULAR NEWS

  • Mobile Health Units With Community Workers Address Critical Hypertension Care Gaps

    Mobile Health Units With Community Workers Address Critical Hypertension Care Gaps

    29 shares
    Share 12 Tweet 7
  • Brazilian EQ-5D Mapping Algorithm Offers Alternative to European-Based Standards

    29 shares
    Share 12 Tweet 7
  • Self-Assembled Berberine-Gallic Acid Nanorods Ameliorate Ulcerative Colitis in Mice

    29 shares
    Share 12 Tweet 7
  • Tablet Augmented Reality System May Reduce Preoperative Anxiety in Pediatric Surgical Patients

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Guiding Wave-Like Fisher Information Flow Enhances Nanophotonic Optical Metrology Precision

Subjective Cognitive Decline Prediction Models Face High Bias Risk and Limited Validation

Realist Review Identifies Key Strategies for Remote Health Workforce Retention

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.